{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:24:40Z","timestamp":1778999080127,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Haemolytic uraemic syndrome (HUS) is a severe syndrome that causes a substantial burden for patients and their families and is the leading cause of acute kidney injury in children. However, data on the epidemiology and disease burden of HUS in Asia, including China, are limited. We aimed to estimate the incidence and cost of HUS in China.\u00a0<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data about HUS from 2012 to 2016 were extracted from the Urban Employee Basic Medical Insurance (UEBMI) and Urban Resident Basic Medical Insurance (URBMI) databases. All cases were identified by ICD code and Chinese diagnostic terms. The 2016 national incidence rates were estimated and stratified by sex, age and season. The associated medical costs were also calculated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The crude incidence of HUS was 0.66 per 100,000 person-years (95% CI: 0.35 to 1.06), and the standardized incidence was 0.57 (0.19 to 1.18). The incidence of HUS in males was slightly higher than that in females. The age group with the highest incidence of HUS was patients\u2009&lt;\u20091\u00a0year old (5.08, 95% CI: 0.23 to 24.87), and the season with the highest incidence was autumn, followed by winter. The average cost of HUS was 2.15 thousand US dollars per patient, which was higher than the national average cost for all inpatients in the same period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the first population-based study on the incidence of HUS in urban China. The age and seasonal distributions of HUS in urban China are different from those in most developed countries, suggesting a difference in aetiology.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02746-2","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:39:07Z","timestamp":1648658347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Incidence and cost of haemolytic uraemic syndrome in urban China: a national population-based analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Jingnan","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuhui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guozhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"issue":"1","key":"2746_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","volume":"31","author":"C Loirat","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016;31(1):15\u201339. https:\/\/doi.org\/10.1007\/s00467-015-3076-8.","journal-title":"Pediatr Nephrol"},{"issue":"9464","key":"2746_CR2","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/s0140-6736(05)71144-2","volume":"365","author":"PI Tarr","year":"2005","unstructured":"Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365(9464):1073\u201386. https:\/\/doi.org\/10.1016\/s0140-6736(05)71144-2.","journal-title":"Lancet"},{"issue":"3","key":"2746_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","volume":"91","author":"TH Goodship","year":"2017","unstructured":"Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Fr\u00e9meaux-Bacchi V, Kavanagh D, et al. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference. Kidney Int. 2017;91(3):539\u201351. https:\/\/doi.org\/10.1016\/j.kint.2016.10.005.","journal-title":"Kidney Int"},{"issue":"6","key":"2746_CR4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.2215\/cjn.11830720","volume":"16","author":"M Lemaire","year":"2021","unstructured":"Lemaire M, Noone D, Lapeyraque AL, Licht C, Fr\u00e9meaux-Bacchi V. Inherited kidney complement diseases. Clin J Am Soc Nephrol. 2021;16(6):942\u201356. https:\/\/doi.org\/10.2215\/cjn.11830720.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2746_CR5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1681\/asn.2004100861","volume":"16","author":"M Noris","year":"2005","unstructured":"Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16(4):1035\u201350. https:\/\/doi.org\/10.1681\/asn.2004100861.","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 3","key":"2746_CR6","first-page":"22","volume":"66","author":"MG Caletti","year":"2006","unstructured":"Caletti MG, Petetta D, Jaitt M, Casaliba S, Gimenez A. Hemolytic uremic syndrome (HUS): medical and social costs of treatment. Medicina. 2006;66(Suppl 3):22\u20136.","journal-title":"Medicina"},{"issue":"23","key":"2746_CR7","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013;368(23):2169\u201381. https:\/\/doi.org\/10.1056\/NEJMoa1208981.","journal-title":"N Engl J Med"},{"issue":"3","key":"2746_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","volume":"60","author":"P Ruggenenti","year":"2001","unstructured":"Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001;60(3):831\u201346. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.060003831.x.","journal-title":"Kidney Int"},{"key":"2746_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2458-12-63","volume":"12","author":"H Vally","year":"2012","unstructured":"Vally H, Hall G, Dyda A, Raupach J, Knope K, Combs B, et al. Epidemiology of shiga toxin producing escherichia coli in Australia, 2000\u20132010. BMC Public Health. 2012;12:63. https:\/\/doi.org\/10.1186\/1471-2458-12-63.","journal-title":"BMC Public Health"},{"key":"2746_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/CLEP.S245642","volume":"12","author":"K Yan","year":"2020","unstructured":"Yan K, Desai K, Gullapalli L, Druyts E, Balijepalli C. Epidemiology of atypical hemolytic uremic syndrome: a systematic literature review. Clin Epidemiol. 2020;12:295\u2013305. https:\/\/doi.org\/10.2147\/CLEP.S245642.","journal-title":"Clin Epidemiol"},{"issue":"40","key":"2746_CR11","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.3760\/cma.j.issn.0376-2491.2018.40.012","volume":"98","author":"XM Shi","year":"2018","unstructured":"Shi XM, Liu H, Wang L, Wang ZX, Dong CY, Wang YF, et al. Study on the current situation of China\u2019s first list of rare diseases based on 15 million hospitalizations. Zhonghua Yi Xue Za Zhi. 2018;98(40):3274\u20138. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2018.40.012.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"10","key":"2746_CR12","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/cid\/cis196","volume":"54","author":"A Rosales","year":"2012","unstructured":"Rosales A, Hofer J, Zimmerhackl LB, Jungraithmayr TC, Riedl M, Giner T, et al. Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis. 2012;54(10):1413\u201321. https:\/\/doi.org\/10.1093\/cid\/cis196.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2746_CR13","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974\u20138. https:\/\/doi.org\/10.1136\/jech-2013-203104.","journal-title":"J Epidemiol Community Health"},{"issue":"8","key":"2746_CR14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17213","volume":"13","author":"JF Torti","year":"2021","unstructured":"Torti JF, Cuervo P, Nardello A, Pizarro M. Epidemiology and characterization of shiga toxin-producing escherichia coli of hemolytic uremic syndrome in Argentina. Cureus. 2021;13(8): e17213. https:\/\/doi.org\/10.7759\/cureus.17213.","journal-title":"Cureus"},{"issue":"10","key":"2746_CR15","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3201\/eid0910.020254","volume":"9","author":"JP Haack","year":"2003","unstructured":"Haack JP, Jelacic S, Besser TE, Weinberger E, Kirk DJ, McKee GL, et al. Escherichia coli o157 exposure in wyoming and seattle: serologic evidence of rural risk. Emerg Infect Dis. 2003;9(10):1226\u201331. https:\/\/doi.org\/10.3201\/eid0910.020254.","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"2746_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1056\/NEJMoa020524","volume":"347","author":"JA Crump","year":"2002","unstructured":"Crump JA, Sulka AC, Langer AJ, Schaben C, Crielly AS, Gage R, et al. An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm. N Engl J Med. 2002;347(8):555\u201360. https:\/\/doi.org\/10.1056\/NEJMoa020524.","journal-title":"N Engl J Med"},{"issue":"3","key":"2746_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1538-7836.2006.01807.x","volume":"4","author":"M Karimi","year":"2006","unstructured":"Karimi M, Sabzi A, Peyvandi F, Mannucci PM. Changing epidemiology of the hemolytic uremic syndrome and thrombotic thrombocytopenic purpura in southern Iran. Journal of thrombosis and haemostasis\u202f: JTH. 2006;4(3):701\u20132. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01807.x.","journal-title":"Journal of thrombosis and haemostasis : JTH"},{"issue":"11","key":"2746_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.15585\/mmwr.mm6711a3","volume":"67","author":"Mph EP Marder","year":"2018","unstructured":"Marder Mph EP, Griffin PM, Cieslak PR, Dunn J, Hurd S, Jervis R, et al. Preliminary incidence and trends of infections with pathogens transmitted commonly through food - foodborne diseases active surveillance network, 10 U.S. Sites, 2006-2017. MMWR Morb Mortal Wkly Rep. 2018;67(11):324\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"2746_CR19","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.3390\/ijerph10083634","volume":"10","author":"JJ Quinlan","year":"2013","unstructured":"Quinlan JJ. Foodborne illness incidence rates and food safety risks for populations of low socioeconomic status and minority race\/ethnicity: a review of the literature. Int J Environ Res Public Health. 2013;10(8):3634\u201352. https:\/\/doi.org\/10.3390\/ijerph10083634.","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"2746_CR20","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3201\/eid2109.150277","volume":"21","author":"BM Whitney","year":"2015","unstructured":"Whitney BM, Mainero C, Humes E, Hurd S, Niccolai L, Hadler JL. Socioeconomic status and foodborne pathogens in connecticut, USA, 2000\u20132011(1). Emerg Infect Dis. 2015;21(9):1617\u201324. https:\/\/doi.org\/10.3201\/eid2109.150277.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"2746_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/bf02254233","volume":"9","author":"KJ Sheth","year":"1995","unstructured":"Sheth KJ, Gill JC, Havens PL, Leichter HE. Racial incidence of hemolytic-uremic syndrome. Pediatr Nephrol. 1995;9(3):401. https:\/\/doi.org\/10.1007\/bf02254233.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2746_CR22","first-page":"54","volume":"12","author":"CY Wang","year":"2017","unstructured":"Wang CY, Shen Q, Sun L, Li GM, Wu BB, Xu H. Analysis of genotype-phenotype correlation in 14 patients with atypical hemolytic uremic syndrome. Chinese Journal of Evidence-Based Pediatrics. 2017;12(1):54\u20139.","journal-title":"Chinese Journal of Evidence-Based Pediatrics"},{"issue":"3","key":"2746_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/ped.12549","volume":"57","author":"JM Lee","year":"2015","unstructured":"Lee JM, Park YS, Lee JH, Park SJ, Shin JI, Park YH, et al. Atypical hemolytic uremic syndrome: Korean pediatric series. Pediatr Int. 2015;57(3):431\u20138. https:\/\/doi.org\/10.1111\/ped.12549.","journal-title":"Pediatr Int"},{"issue":"19","key":"2746_CR24","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1106483","volume":"365","author":"C Frank","year":"2011","unstructured":"Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden, et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med. 2011;365(19):1771\u201380. https:\/\/doi.org\/10.1056\/NEJMoa1106483.","journal-title":"N Engl J Med"},{"issue":"2","key":"2746_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/01.ede.0000113273.14807.53","volume":"15","author":"DP Miller","year":"2004","unstructured":"Miller DP, Kaye JA, Shea K, Ziyadeh N, Cali C, Black C, et al. Incidence of thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome. Epidemiology. 2004;15(2):208\u201315. https:\/\/doi.org\/10.1097\/01.ede.0000113273.14807.53.","journal-title":"Epidemiology"},{"issue":"4","key":"2746_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00431-015-2642-1","volume":"175","author":"G Ardissino","year":"2016","unstructured":"Ardissino G, Salardi S, Colombo E, Testa S, Borsa-Ghiringhelli N, Paglialonga F, et al. Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network. Eur J Pediatr. 2016;175(4):465\u201373. https:\/\/doi.org\/10.1007\/s00431-015-2642-1.","journal-title":"Eur J Pediatr."},{"issue":"8","key":"2746_CR27","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1681\/asn.2006080811","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2007;18(8):2392\u2013400. https:\/\/doi.org\/10.1681\/asn.2006080811.","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"2746_CR28","first-page":"1022","volume":"33","author":"Pediatric Blood Purification Specialist Commite of Pediatric Association in Chinese Medical Doctor Association","year":"2018","unstructured":"Pediatric Blood Purification Specialist Commite of Pediatric Association in Chinese Medical Doctor Association. A multi-center epidemiological investigation on therapeutic plasma exchange for the children with hemolytic uremic syndrome. Chin J Appl Clin Pediatr. 2018;33(13):1022\u20137.","journal-title":"Chin J Appl Clin Pediatr"},{"issue":"1","key":"2746_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/16078454.2020.1731969","volume":"25","author":"J Li","year":"2020","unstructured":"Li J, Song Y, Zhang Y, Li H, Tian M, Li D, et al. A novel compound heterozygous mutation in DGKE in a Chinese patient causes atypical hemolytic uremic syndrome. Hematol (Amsterdam, Netherlands). 2020;25(1):101\u20137. https:\/\/doi.org\/10.1080\/16078454.2020.1731969.","journal-title":"Hematol (Amsterdam, Netherlands)"},{"issue":"3","key":"2746_CR30","first-page":"237","volume":"17","author":"CC So","year":"2011","unstructured":"So CC, Leung YY, Yip SF, Chan SY, Lam CC, Chan GC, et al. Common association of haemolytic uraemic syndrome with invasive Streptococcus pneumoniae infection in five Chinese paediatric patients. Hong Kong Med J = Xianggang yi xue za zhi. 2011;17(3):237\u201341.","journal-title":"Hong Kong Med J = Xianggang yi xue za zhi."},{"issue":"1","key":"2746_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1440-1797.2011.01500.x","volume":"17","author":"CS Lee","year":"2012","unstructured":"Lee CS, Chen MJ, Chiou YH, Shen CF, Wu CY, Chiou YY. Invasive pneumococcal pneumonia is the major cause of paediatric haemolytic-uraemic syndrome in Taiwan. Nephrol (Carlton). 2012;17(1):48\u201352. https:\/\/doi.org\/10.1111\/j.1440-1797.2011.01500.x.","journal-title":"Nephrol (Carlton)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02746-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02746-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02746-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:39:33Z","timestamp":1648658373000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02746-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2746"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02746-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and method were consistent with the ethical principles of the Helsinki Declaration and approved by the ethics review committee of the Peking University Health Science Center, and the need to obtain informed consent was waived (IRB00001052-18012).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}